D’OXYVA® (deoxyhemoglobin vasodilator) is the first biotech solution of its kind that is clinically validated to significantly improve macro-, and micro-circulation of blood flow and certain nerve activities in the body, which together are widely reported to form an effective treatment option for many conditions.
We guarantee clinical outcomes typically in 4-8 weeks by following customized D’OXYVA protocols of 5-10 minutes daily in the comfort of your home or on the go.
CHOOSE YOUR D’OXYVA THERAPY GOAL TO PROCEED
The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.
The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.
Patients should always ask their doctors for medical advice about adverse events.
You may report an adverse event related to Circularity products by calling 1-855-536-9982 (US only). If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly. The FDA has established a reporting service known as MedWatch where healthcare professionals and consumers can report serious problems they suspect may be associated with the drugs and medical devices they prescribe, dispense, or use. Visit MedWatch.com or call 1-800-FDA-1088.
Copyright © 2019 Circularity Healthcare LLC. All Rights Reserved.